SCHEMBL26114530

SCHEMBL26114530

C/C=C1\CN(Cc2ccccc2)C1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD3 P35462 1/20 0.44
KCNH2 Q12809 1/20 0.44
PARP1 P09874 1/20 0.43
EPHX2 P34913 1/20 0.43
DDB1 Q16531 1/20 0.42
CRBN Q96SW2 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
CASP3 P42574 1/20 0.42
KMT2A Q03164 4/20 0.41
MEN1 O00255 3/20 0.41
POLB P06746 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
MAPK1 P28482 1/20 0.41
F2 P00734 1/20 0.41
PLG P00747 1/20 0.41
ELANE P08246 1/20 0.41
CTSG P08311 1/20 0.41
CMA1 P23946 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26112971 1.00 DRD3 (0.44) DRD3KCNH2PARP1EPHX2DDB1
SCHEMBL26112976 1.00 DRD3 (0.44) DRD3KCNH2PARP1EPHX2DDB1
SCHEMBL26111496 0.81 GAA (0.50) CASP3KMT2AMEN1POLBMAPK1
SCHEMBL26111499 0.81 GAA (0.50) CASP3KMT2AMEN1POLBMAPK1
SCHEMBL26115953 0.81 GAA (0.50) CASP3KMT2AMEN1POLBMAPK1
SCHEMBL6300356 0.76 EPHX2 (0.55) PARP1EPHX2DDB1CRBNCASP3
SCHEMBL26113746 0.76 PARP1 (0.49) DRD3KCNH2PARP1EPHX2DDB1
SCHEMBL9766509 0.74 CASP3 (0.46) DRD3KCNH2PARP1EPHX2DDB1
SCHEMBL7248991 0.73 PARP1 (0.47) DRD3KCNH2PARP1EPHX2DDB1
SCHEMBL6154136 0.71 PARP1 (0.46) DRD3KCNH2PARP1EPHX2DDB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12421187-B2 Dihydrofolate synthase (DHFS) inhibiting agents and methods of making and using same WASHINGTON UNIVERISTY (US) 2025-09-23 US disclosed
US-20230322667-A1 DIHYDROFOLATE SYNTHASE (DHFS) INHIBITING AGENTS AND METHODS OF MAKING AND USING SAME WASHINGTON UNIVERSITY (US) 2023-10-12 US disclosed
US-20230322667-A1 DIHYDROFOLATE SYNTHASE (DHFS) INHIBITING AGENTS AND METHODS OF MAKING AND USING SAME WASHINGTON UNIVERSITY (US) 2023-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230322667-A1 DIHYDROFOLATE SYNTHASE (DHFS) INHIBITING AGENTS AND METHODS OF MAKING AND USING SAME DHFR, DHPS, MTHFD1 DRD3 4669/4885KCNH2 4620/4885PARP1 1425/4885
US-12421187-B2 Dihydrofolate synthase (DHFS) inhibiting agents and methods of making and using same DHFR, DHPS, MTHFD1 DRD3 4669/4885KCNH2 4620/4885PARP1 1425/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.